Publications by authors named "M Raschack"

Claim this Profile
E
Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteries.
Gunnar Tepe, Ute Brehme, Harald Seeger, Manfred Raschack, Claus D Claussen

Invest Radiol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.
B Hocher, A Schwarz, D Reinbacher, J Jacobi, A Lun, M Raschack

Nephron· February 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth.
S R Orth, K Amann, F Gehlen, L Unger, J Wagner, M Raschack

J Cardiovasc Pharmacol· November 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
B Merkely, T Szabó, L Gellér, O Kiss, F Horkay, M Raschack

J Cardiovasc Pharmacol· November 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
O Kiss, L Gellér, B Merkely, T Szabó, M Raschack

J Cardiovasc Pharmacol· November 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis